Professional Documents
Culture Documents
ORIGINAL ARTICLE
Department of Pharmaceutical Chemistry, STES’s Sinhgad Institute of Pharmacy, Narhe, Pune 411041, India
KEYWORDS Abstract A novel series of 2-Chloroquinoline nucleus clubbed with the pyrazole ring has been
Quinoline; synthesized and screened for antibacterial and antifungal activity. The results obtained were prom-
Pyrazole; ising against both bacterial and fungal strains. Among the series, compound MB-N was found
Antibacterial; moderately active against Aspergillus fumigatus, Penicillium notatum and Bacillus subtilis having
Antifungal MIC 48, 46 and 44 lg/ml, respectively whereas compound MB-A was found active against P. not-
atum, B. subtilis and Escherichia coli having MIC 57, 54 and 43 lg/ml, respectively as compared to
standard.
ª 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.
Please cite this article in press as: P.B. Miniyar et al., Synthesis and biological evaluation of 1-(5-(2-chloroquinolin-3-yl)-3-phenyl-1H-pyrazol- 1-yl)etha-
none derivatives as potential antimicrobial agents, Journal of Saudi Chemical Society (2014), http://dx.doi.org/10.1016/j.jscs.2013.12.004
2 P.B. Miniyar et al.
above observations and considering the significant role of 2.1.2. Step 2: synthesis of 2-chloroquinoline chalcones [2]
quinoline and pyrazoline in biological applications, we wish In a round bottom flask equipped with sealed mechanical
to report here the synthesis of a new series of quinolines– stirrer, 40% sodium hydroxide solution and 15–20 ml metha-
pyrazoline derivatives and their anti-microbial activities. nol were stirred in an ice-bath. Then compounds 2a–2c
(1 mol) and substituted acetophenones (1 mol) were added into
2. Method the above mixture and stirred for 24 h at room temperature. At
the end of the period, the reaction mixture was poured in ice
2.1. Experimental cold water, neutralized with dilute hydrochloric acid and the
resultant solid was filtered, dried to give titled compounds
Conventional method of synthesis has drawbacks of lower 3a–3f. Scheme of synthesis of 2-chloroquinoline chalcones is
yields and being time consuming. Here we have made attempts described in Fig. 2 and their characterization data in Table 2.
to report novel chloroquinoline derivatives by combination of
both conventional as well as microwave irradiation method. 2.1.3. Step 3: synthesis of 2-chloroquinoline pyrazole derivatives
Purity of starting materials was confirmed by TLC using [4]
Merck silica gel precoated plate and with appropriate solvent A mixture of compounds 3a–3f (1.0 mmol), hydrazine hydrate
system. All the melting points were recorded on a Veego appa- (1.3 mmol) and AcOH (10 ml) was placed into an open Pyrex-
ratus and were uncorrected. IR spectra were recorded on Jasco glass vessel. The above mixtures were subjected to microwave
model 4100 FI-IR (KBr Pellet in the 4000-400 cm1 range). irradiation with magnetic stirring for 5–7 min and with a max-
The 1H NMR spectra were obtained at 300 MHz in CDCl3, imum power of 300 W. Reaction progress was monitored by
by using Varian instrument using TMS as internal standard TLC and the reaction mixture was poured in ice cold water.
and chemical shift values are given in ppm downfield to The precipitate formed was filtered off and recrystallized from
TMS (tetramethylsilane). ESI-MS was recorded on a Micro- ethanol to yield MB-A to MB-BB. Scheme of synthesis of
mass Quattro II triple quadrupole mass spectrometer. The 2-chloroquinoline pyrazole derivatives is described in Fig. 3
starting material acetanilide (1a) was procured from commer- and their characterization data in Table 3.
cial source and p-bromo (1b) and p-nitro acetanilide (1c) were
prepared from acetanilide by standard procedure reported by 2.2. Spectral characterizations of synthesized compounds MB A
Furniss et al [23]. –BB are given below
Please cite this article in press as: P.B. Miniyar et al., Synthesis and biological evaluation of 1-(5-(2-chloroquinolin-3-yl)-3-phenyl-1H-pyrazol- 1-yl)etha-
none derivatives as potential antimicrobial agents, Journal of Saudi Chemical Society (2014), http://dx.doi.org/10.1016/j.jscs.2013.12.004
Synthesis and biological evaluation of 1-(5-(2-chloroquinolin-3-yl)-3-phenyl-1H-pyrazol-1-yl)ethanone 3
CH3 O
R CHO R
R'
2a-2c 3a-3f
Compound R R'
code
3a H H
3b H Br
3c H F
3d H NH2
3e NO2 Br
3f Br Br
O H3COC
N N
R R'
i) Glacial acetic acid, NH2-NH2 .H2O R
Please cite this article in press as: P.B. Miniyar et al., Synthesis and biological evaluation of 1-(5-(2-chloroquinolin-3-yl)-3-phenyl-1H-pyrazol- 1-yl)etha-
none derivatives as potential antimicrobial agents, Journal of Saudi Chemical Society (2014), http://dx.doi.org/10.1016/j.jscs.2013.12.004
4 P.B. Miniyar et al.
(s, 2H, aromatic), 5.02 (s, 1H, pyrazole), 2.65 (s, 1H, CH3).
Table 4 MIC values (lg/ml) against S. aureus, B. subtilis,
MS: m/z 388.23 (M+Na)+.
E. coli.
2.2.4. MB-N: 1-(3-(4-aminophenyl)-5-(2-chloroquinolin-3-yl)- Compound code S. aureus B. subtilis E. coli
1H-pyrazol-1-yl)ethanone MB-A 200 54 43
IR (KBr): v cm1 (C‚O) 1670.05, (N–H) 3341.07, (C–H) MB-Br 213 103 77
MB-F 245 82 93
3021.26, (C‚N) 1559.17, (C–Cl) 780.78. 1H NMR
MB-N 225 44 87
(300 MHz CDCl3) d: 8.51 (s, 1H, Quinoline), 8.05 (s, 1H,
MB-BN 246 108 97
Quinoline), 7.57–7.59 (s, 2H, quinoline), 7.43–7.70 (s,3H,quin- MB-BB 289 104 96
oline), 7.53 (s, 2H, aromatic), 6.52 (s, 2H, aromatic), 4.85 (s, Gatifloxacin 32.5 30 28.5
1H, pyrazole), 4.23(s, 2H,aromatic amine), 2.78 (s, 1H, CH3).
Please cite this article in press as: P.B. Miniyar et al., Synthesis and biological evaluation of 1-(5-(2-chloroquinolin-3-yl)-3-phenyl-1H-pyrazol- 1-yl)etha-
none derivatives as potential antimicrobial agents, Journal of Saudi Chemical Society (2014), http://dx.doi.org/10.1016/j.jscs.2013.12.004
Synthesis and biological evaluation of 1-(5-(2-chloroquinolin-3-yl)-3-phenyl-1H-pyrazol-1-yl)ethanone 5
Figure 4 MIC of synthesized compounds in comparison with standard against different microbial strains.
antibacterial as well as antifungal activity. The chloro substitu- 1H-pyrazol-5-yl)-1-phenyl-1H-pyrazole derivatives as potential
tion at 2-position was a key factor for both antibacterial as antitumor agents, Bioorg. Med. Chem. 18 (2010) 4965–4974.
well as antifungal activities. [5] M. Johnson, B. Younglove, L. Lee, R. Leblanc, H. Holt, P.
Hills, et al, Design, synthesis, and biological testing of
pyrazoline derivatives of combretastatin-A4, Bioorg. Med.
4. Conclusion Chem. Lett. 17 (2007) 5897–5901.
[6] P.A. Leatham, H.A. Bird, V. Wright, D. Seymour, A.
A series of 2-chloroquinolines condensed with pyrazole nu- Gordon, A double blind study of antrafenine, naproxen and
cleus have been synthesized and evaluated for antibacterial placebo in osteoarthrosis, Eur. J. Rheumatol. Inflamm. 6
and antifungal activity. The compound MB-N was found to (1983) 209–211.
be having moderate activity against A. fumigatus and P. nota- [7] J.M. Lilienkampf, B.Y. Wan, S.G. Wang, A.P. Franzblau,
Structure–activity relationships for a series of quinoline-based
tum, whereas compounds MB-A and MB-F were found active
compounds active against replicating and nonreplicating
against P. notatum. As far as antibacterial activity is concerned Mycobacterium tuberculosis, J. Med. Chem. 52 (2009) 2109–
compound MB-A showed good activity against B. subtillis and 2118.
E. coli whereas compound MB-N has promising activity only [8] A. Loupy, A. Petit, J. Hamelin, F. Texier-Boullet, P. Jacquault,
against B. subtillis. All the synthesized compounds showed D. Mathe, New solvent free organic synthesis using focused
very poor activity against S. aureus. microwaves, Synthesis (1998) 1213–1217.
So, the results obtained from antibacterial and antifungal [9] M.P. Maguire, K.R. Sheets, K. McVety, A.P. Spada, A.
activities are more promising as the compounds showed signif- Zilberstein, A new series of PDGF receptor tyrosine kinase
icant activity as compared to standard or marketed drugs, inhibitors: 3-substituted quinoline derivatives, J. Med. Chem. 37
Gatifloxaicn and Fluconazole. These results can be used fur- (1994) 2129–2137.
[10] A. Mahamoud, J. Chevalier, A. Davin-Regli, J. Barbe, P. Jean-
ther to design and develop novel antimicrobial agents.
Marie, Quinoline derivatives as promising inhibitors of
antibiotic efflux pump in multidrug resistant Enterobacter
aerogenes isolates, Curr. Drug Targets 7 (2006) 843–847.
Acknowledgement [11] M.C. McManus, Mechanisms of bacterial resistance to
antimicrobial agents, Am. J. Health Syst. Pharm. 54 (1997)
The authors thank Dr. K.G. Bothara, Principal, Sinhgad Insti- 1420–1433.
tute of Pharmacy, Narhe, Pune for providing research facility. [12] N. Muruganantham, R. Sivakumar, N. Anbalagan, V.
Gunasekaran, J.T. Leonard, Synthesis, anticonvulsant and
The authors also thank the University of Pune for 1H NMR
antihypertensive activities of 8-substituted quinoline
and I.I.C.B., Calcutta for Mass spectral analysis.
derivatives, Biol. Pharm. Bull. 27 (2004) 1683–1687.
[13] P. Nasveld, S. Kitchener, Treatment of acute vivax malaria with
References tafenoquine, Trans. R. Soc. Trop. Med. Hyg. 99 (2005) 2–5.
[14] A. Rattan, Antimicrob. Lab. Med. B, Churchill Livingstone,
[1] W.A. Denny, W.R. Wilson, D.C. Ware, D.J. Atwell, J.B. New Delhi, 2005, pp. 85–90, Chapter 5.
Milbank, R.J. Stevenson, U.S Patent 7064117 (2006). [15] M.V. Reddy, V.K. Bila, V.R. Pallela, M.R. Mallireddigari, R.
[2] J.N. Dominguez, C. Leon, J. Rodrigues, N.G. Dominguez, J. Boominathan, J.L. Gabriel, Design, synthesis, and biological
Gut, P.J. Rosenthal, Synthesis of chlorovinyl sulfones as evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl
structural analogs of chalcones and their antiplasmodial pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase
activities, Eur. J. Med. Chem. 44 (2009) 1457–1462. (LOX) inhibitors, Bioorg. Med. Chem. 16 (2008) 3907–3916.
[3] S. Eswaran, A.S. Adhikari, N.S. Shetty, Synthesis and [16] N.M. Shah, M.P. Patel, R.G. Patel, New N-arylamino
antimicrobial activities of novel quinoline derivatives carrying biquinoline derivatives: synthesis, antimicrobial,
1,2,4-triazole moiety, Eur. J. Med. Chem. 44 (2009) 4637–4647. antituberculosis, and antimalarial evaluation, Eur. J. Med.
[4] B. Insuasty, A. Tigreros, F. Orozco, J. Quiroga, R. Abonı́a, M. Chem. 54 (2012) 239–247.
Nogueras, A. Sanchez, J. Cobo, Synthesis of novel pyrazolic [17] Y.M. Shahar, M.A. Bakht, A.A. Siddiqui, M.M. Abdullah, C.E.
analogues of chalcones and their 3-aryl-4-(3-aryl-4,5-dihydro- De, Synthesis and evaluation of in vitro antiviral activity of
Please cite this article in press as: P.B. Miniyar et al., Synthesis and biological evaluation of 1-(5-(2-chloroquinolin-3-yl)-3-phenyl-1H-pyrazol- 1-yl)etha-
none derivatives as potential antimicrobial agents, Journal of Saudi Chemical Society (2014), http://dx.doi.org/10.1016/j.jscs.2013.12.004
6 P.B. Miniyar et al.
novel phenoxy acetic acid derivatives, J. Enzyme Inhib. Med. [21] W.D. Wilson, M. Zhao, S.E. Patterson, R.L. Wydra, L. Janda, L.
Chem. 24 (2009) 876–882. Strekowski, Design of RNA interactive anti-HIV agents: unfused
[18] M. Shaharyar, A.A. Siddiqui, M.A. Ali, D. Sriram, P. aromatic intercalators, Med. Chem. Res. 2 (1992) 102–110.
Yogeeswari, Synthesis and in vitro antimycobacterial activity [22] D. Zampieri, M.G. Mamolo, E. Laurii, G. Scialino, E. Banfi,
of N1-nicotinoyl-3-(40 -hydroxy-30 -methyl phenyl)-5- Antifungal and antimycobacterial activity of 1-(3,5-diaryl-4,5-
[(sub)phenyl]-2-pyrazolines, Bioorg. Med. Chem. Lett. 13 dihydro-1H-pyrazol-4-yl)-1H-imidazole derivatives, Bioorg.
(2006) 2213–2220. Med. Chem. 16 (2008) 4516–4522.
[19] L. Strekowski, J.L. Mokrosz, V.A. Honkan, A.M. Czarny, T. [23] B.S. Furniss, A.J. Hannaford, P.W.G. Smith, A.R. Tatchell, in:
Cegla, S.E. Patterson, R.L. Wydra, R.F. Schinazi, Synthesis and Vogel’s Textbook of Practical Organic Chemistry 5th ed., CBS
quantitative structure-activity relationship analysis of 2-(aryl or Publishers, New Delhi, pp 919.
heteroaryl)quinolin-4-amines, a new class of anti-HIV-1 agents, [24] O. Meth-Cohn, B. Narine, B. Tarnowski, A versatile new
J. Med. Chem. 34 (1991) 1739–1746. synthesis of quinolines and related fused pyridines, Part 5. The
[20] K. Tanaka, F. Toda, Solvent-free organic synthesis, Chem. Rev. synthesis of 2-chloroquinoline-3- carbaldehydes, J. Chem. Soc.
100 (2000) 1025–1074. Perkin Trans. 1 (1981) 1520–1530.
Please cite this article in press as: P.B. Miniyar et al., Synthesis and biological evaluation of 1-(5-(2-chloroquinolin-3-yl)-3-phenyl-1H-pyrazol- 1-yl)etha-
none derivatives as potential antimicrobial agents, Journal of Saudi Chemical Society (2014), http://dx.doi.org/10.1016/j.jscs.2013.12.004